In one paragraphArticle in Drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Tatyana AppelbaumDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-8765-4792 David A SmithDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0009-0009-9227-6031 Kei TakahashiDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-7455-0465 Jennifer C KwokDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-1995-0095 Hannah SorensonDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0009-0004-9069-9931 William A BeltranDepartment of Clinical Sciences & Advanced Medicine, Division of Experimental Retinal Therapies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-1127-4774 Funding
MODELS OF HEREDITY RETINAL DEGENERATIONR01EY006855 · NEI · UNIVERSITY OF PENNSYLVANIA · PI GUSTAVO David AGUIRRE, William A. Beltran · 1992 to 2026
$20.7MScientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5MTranslational Research for Retinal Degeneration TherapiesR01EY017549 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BELTRAN, WILLIAM A. · 2007 to 2024
$14.1MLeica Stellaris 8 Falcon/FLIM for the PennVet Imaging CoreS10OD032305 · OD · UNIVERSITY OF PENNSYLVANIA · PI FREEDMAN, BRUCE D · 2023 to 2023
$842kNEI NIH HHS P30 EY001583NEI NIH HHS R01 EY006855NEI NIH HHS R01 EY017549NIH HHS S10 OD032305
6 · The paper itselfAbstract
Efficient messenger ribonucleic acid (mRNA) delivery to the retina remains challenging. This study investigated the effects of various polyethylene glycol (PEG) derivatives on the stability and uptake of cationic lipid-based mRNA lipoplexes
Indexed as
Hyaluronic AcidPolyethylene GlycolsRetinaRNA, MessengerAnimalsCell LineDogsGene Transfer TechniquesGreen Fluorescent ProteinsLipidsLiposomesMiceRAW 264.7 CellsRetinal Pigment Epitheliumenhanced green fluorescent proteinGreen Fluorescent ProteinsHyaluronic AcidLipidsLiposomesPolyethylene GlycolsRNA, MessengermRNA lipoplexesNon-viral vectorsPEGylationretinal mRNA deliverystability
Identifiers
PMID40804358
PMCPMC12351706
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390